Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis. [electronic resource]
Producer: 20060824Description: 38 p. digitalISSN:- 1477-7827
- Adult
- Clomiphene -- therapeutic use
- Cost Savings
- Drug Resistance
- Female
- Follicle Stimulating Hormone, Human -- therapeutic use
- Humans
- Infertility, Female -- drug therapy
- Ovulation Induction -- economics
- Polycystic Ovary Syndrome -- drug therapy
- Pregnancy
- Pregnancy Rate
- Recombinant Proteins -- therapeutic use
- Urofollitropin -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.